Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
Lung India
.
2022 Nov-Dec;39(6):587-588.
doi: 10.4103/lungindia.lungindia_355_22.
Authors
Zarir F Udwadia
1
,
Unmesha Prakash Pawar
2
,
Viral Jayshinh Nanda
2
Affiliations
1
Consultant Chest Physician, P.D. Hinduja Hospital and MRC, Mumbai, India.
2
Clinical Assistant, P.D. Hinduja Hospital and MRC, Mumbai, India.
PMID:
36629242
PMCID:
PMC9746276
DOI:
10.4103/lungindia.lungindia_355_22
No abstract available
Publication types
Letter